Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Arm was paralyzed/now she has to have surgery on her arm; This serious case was reported by a consumer via interactive digital media and described the occurrence of arm paralysis in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced arm paralysis (Verbatim: Arm was paralyzed/now she has to have surgery on her arm) (serious criteria GSK medically significant and clinically significant/intervention required). The outcome of the arm paralysis was resolved (duration 8 months). It was unknown if the reporter considered the arm paralysis to be related to Shingrix. The company considered the arm paralysis to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 22-OCT-2025 This case was reported by a patient's neighbor via interactive digital media. The patient said vaccines were a myth. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Monoplegia, unknown time after receiving Shingrix in a female patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.